Vertex Pharmaceuticals, Inc.(NASDAQ : VRTX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|REGN||Regeneron Pharmaceuticals, Inc.||2.71%||461.57||2.7%||$556.12m|
|GILD||Gilead Sciences, Inc.||2.20%||64.62||1.0%||$516.91m|
|VRTX||Vertex Pharmaceuticals, Inc.||2.02%||211.98||1.9%||$458.30m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.11%||150.10||2.0%||$339.49m|
|CRSP||CRISPR Therapeutics AG||-0.73%||114.65||0.6%||$304.78m|
|BNGO||BioNano Genomics, Inc.||3.62%||7.15||0.0%||$275.81m|
|EXAS||EXACT Sciences Corp.||0.51%||121.64||18.4%||$251.13m|
|PACB||Pacific Biosciences of California, Inc.||1.70%||29.27||7.2%||$176.23m|
Vertex Pharmaceuticals, Inc. is a global biotechnology company. It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.